Connect with us

Hi, what are you looking for?

press release

INVESTIGATION OF SHAREHOLDERS: Halper Sadeh LLC investigates ISR, – Press Release

NEW YORK, Nov. 13, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties related to:

Isoray, Inc. ISR‘s Merged with Viewpoint Molecular Targeting, Inc. If you are Isoray shareholder, Click here to learn more about your rights and options.

Solid Biosciences Inc. SLDB‘s Merged with AavantiBio, Inc. If you are a Solid shareholder, Click here to learn more about your rights and options.

Poshmark, Inc. ELEGANT‘s Sale to Naver Corp. for $17.90 per share in cash. If you are a Poshmark shareholder, Click here to learn more about your rights and options.

Orthofix Medical Inc. OFIX‘s Merged with SeaSpine Holdings Corporation. Upon closing of the transaction, Orthofix shareholders will own approximately 56.5% of the combined company. If you are an Orthofix shareholder, Click here to learn more about your rights and options.

Shareholders are encouraged to contact the company for free to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors worldwide who have been victims of securities fraud and corporate wrongdoing. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of deceived investors.

Lawyer…

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...